China (Mainland)
Cjc 1295 with dac CAS NO.863288-34-0
- FOB Price: USD: 107.50-110.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Available Specifications:
dac(1-4)Gramdac(5-9)Gram
- Product Details
Keywords
- Cjc 1295 with dac
- cjc 1295
- cjc
Quick Details
- ProName: Cjc 1295 with dac
- CasNo: 863288-34-0
- Molecular Formula: C152H252N44O42
- Appearance: Lyophilized powder
- Application: body building, health supplement 8632...
- DeliveryTime: 1-3 days
- PackAge: 10vials/kit, box
- Port: shanghai,beijing,guangzhou, HK
- ProductionCapacity: 1000 Metric Ton/Day
- Purity: 2mg/vial,10vials/box
- Storage: Far from fire and heat, keep in cool p...
- Transportation: by express, dhl,tnt,ems
- LimitNum: 1 Gram
- Related Substances: Related protein shall be not more than...
- Residue on Ignition: 0.08%
- Heavy Metal: <1ppm
- Valid Period: 24 months
Superiority
1.Free sample and the price is reasonable.
2.low freight with the fast delivery.
3.payment assurance, 24 hours service,the goods is high purity,
4.It have good effect,good feedback, lead time:1-3 days,
5.payment terms: TT, alibaba, ,
6.factory supplier, recruit overseas agents, welcome inquiry.
CJC-1295 is a long-acting growth hormone releasing hormone that releases more growth hormone from the anterior pituitary. GHRH is released in the form of pulses in vivo, alternating with the corresponding pulses of somatostatin (growth hormone inhibitory hormone). Clinical studies were first conducted in the mid-2000s for CJC-1295. The purpose of this peptide is to treat visceral fat deposition in obese AIDS patients, as an increase in exogenous hgH levels is thought to increase lipolysis (fat reduction). Clinical studies have finally been successfully applied to most subjects.
Details
| Name |
cjc 1295 |
|
| Molecular Formula | C152H252N44O42 | |
| Molecular Weight | 3367.897 | |
| CAS Registry Number | 863288-34-0 | |
| density | 1.4±0.1 g/cm3 | |
| Appearance | Freeze-dried powder | |
| Specification | 2mg/vial | |
| Category | API |
CJC-1295 is a long-acting GHRH analogue that stimulates the secretion of GH and IGF-1. It will maintain a steady increase in HGH and IGF-1 without an increase in prolactin. [1] CJC-1295 represents a very exciting new compound with the potential to increase the secretion and action of growth hormone and IGF-I, with built-in protective measures (feedback of IGF-I) that can limit GH Excessive elevation and IGF-1 levels. Strong fat loss. Increase protein synthesis and increase muscle growth. GHRHKO animals receiving a daily dose of CJC-1295 exhibited normal body weight and length.
Function of cjc 1295
CJC-1295 is a long-acting growth hormone releasing hormone that releases more growth hormone from the anterior pituitary. GHRH is released in the form of pulses in vivo, alternating with the corresponding pulses of somatostatin (growth hormone inhibitory hormone). Clinical studies were first conducted in the mid-2000s for CJC-1295. The purpose of this peptide is to treat visceral fat deposition in obese AIDS patients, as an increase in exogenous hgH levels is thought to increase lipolysis (fat reduction). Clinical studies have finally been successfully applied to most subjects.
COA of cjc 1295